18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: A prospective study in 77 operated patients

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 5, 2009, Pages 1713-1722

  Groussin, Lionel ^a,b,c   Bonardel, Gérald ^g   Silvéra, Stéphane ^b,d   Tissier, Frédérique ^a,b,d   Coste, Joël ^b,e   Abiven, Gwenaelle ^c   Libé, Rossella ^a,c,f   Bienvenu, Marie ^b,d   Alberini, Jean Louis ^j   Salenave, Sylvie ⁱ   Bouchard, Philippe ^h   Bertherat, Jérôme ^a,b,c   Dousset, Bertrand ^b,d   Legmann, Paul ^b,d   Richard, Bruno ^b,d   Foehrenbach, Hervé ^g   Bertagna, Xavier ^a,b,c,f   Tenenbaum, Florence ^d  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Center for Rare Adrenal Diseases ^*  (France)

^d Department of Pathology ^*  (France)

^e Unit of Biostatistics   (France)

^f Department of Digestive and Endocrine Surgery ^*  (France)

^g University of Paris Descartes   (France)

^h HÔPITAL SAINT ANTOINE   (France)

ⁱ BICÊTRE HOSPITAL   (France)

^j LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HYDROCORTISONE; DIAGNOSTIC AGENT; HORMONE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; ADRENAL CORTEX TUMOR; BLOOD; DIABETES MELLITUS; FRANCE; GLUCOSE BLOOD LEVEL; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; PROSPECTIVE STUDY; SCINTISCANNING;

ADRENAL CORTEX NEOPLASMS; ADULT; AGED; BLOOD GLUCOSE; DIABETES COMPLICATIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HORMONES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PARIS; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66149143622     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2302     Document Type: Article

References (47)

1. Young Jr WF 2007 Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356:601-610
2. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS 2003 Management of the clinically inapparent adrenal mass ("incidentaloma") . Ann Intern Med 138:424-429 (Pubitemid 36262654)
3. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C 2001 Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25:891-897 (Pubitemid 32666390)
4. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J 2006 Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91:2650-2655 (Pubitemid 44024632)
5. Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H, Schoellnast H, Preidler KW, Samonigg H 2005 Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234:479-485 (Pubitemid 40139919)
6. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F 1998 CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170:747-752 (Pubitemid 28106677)
7. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR 2000 Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798-802
8. Rohren EM, Turkington TG, Coleman RE 2004 Clinical applications of PET in oncology. Radiology 231:305-332 (Pubitemid 38552885)
9. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y 2001 Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 61:6762-6767 (Pubitemid 32896498)
10. Luton JP, Martinez M, Coste J, Bertherat J 2000 Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center. Eur J Endocrinol 143:111-117 (Pubitemid 30482208)
11. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H 2005 In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 90:1302-1310
12. Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere AM, Rene- Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J 2005 Mutations of β-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65:7622-7627 (Pubitemid 41297234)
13. d'Alva C, Abiven-Lepage G, Viallon V, Groussin L, Dugue MA, Bertagna X, Bertherat J 2008 Sex steroids in androgen-secreting adrenocortical tumors: clinical and hormonal features in comparison with nontumoral causes of androgen excess. Eur J Endocrinol 159:641-647
14. Sullivan M, Boileau M, Hodges CV 1978 Adrenal cortical carcinoma. J Urol 120:660-665 (Pubitemid 9091388)
15. Campbell G 1994 Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med 13:499-508 (Pubitemid 24106732)
16. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B 1995 Incidentally discovered adrenal masses. Endocr Rev 16:460-484
17. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M 2006 Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298-302 (Pubitemid 43905318)
18. Becherer A, Vierhapper H, Potzi C, Karanikas G, Kurtaran A, Schmaljohann J, Staudenherz A, Dudczak R, Kletter K 2001 FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 16:289-295 (Pubitemid 32938868)
19. Leboulleux S, Dromain C, Bonniaud G, Auperin A, Caillou B, Lumbroso J, Sigal R, Baudin E, Schlumberger M 2006 Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab 91:920-925 (Pubitemid 43357759)
20. Mackie GC, Shulkin BL, Ribeiro RC, Worden FP, Gauger PG, Mody RJ, Connolly LP, Kunter G, Rodriguez-Galindo C, Wallis JW, Hurwitz CA, Schteingart DE 2006 Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 91:2665-2671
21. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC 1999 Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology 212:35-41 (Pubitemid 29302508)
22. Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, Mueller PR 1995 Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 194: 131-134 (Pubitemid 24380938)
23. Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A 2001 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795-1799 (Pubitemid 34016347)
24. Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, Kung J, Zhuang H, Alavi A 2004 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 45:2058-2062 (Pubitemid 47611636)
25. Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, Boland GW 2006 Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 238:970-977 (Pubitemid 43289929)
26. Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD 2006 FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 33:29-35 (Pubitemid 41785306)
27. Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E 2006 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47:32-37 (Pubitemid 46768509)
28. Caoili EM, Korobkin M, Brown RK, Mackie G, Shulkin BL 2007 Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation. Acad Radiol 14:468-475
29. Erasmus JJ, Patz Jr EF, McAdams HP, Murray JG, Herndon J, Coleman RE, Goodman PC 1997 Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168:1357-1360
30. Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M 2001 The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. J Nucl Med 42:884-892
31. Han SJ, Kim TS, Jeon SW, Jeong SJ, Yun M, Rhee Y, Kang ES, Cha BS, Lee EJ, Lee HC, Lim SK 2007 Analysis of adrenal masses by 18F-FDG positron emission tomography scanning. Int J Clin Pract 61:802-809
32. Tessonnier L, Sebag F, Palazzo FF, Colavolpe C, De Micco C, Mancini J, Conte-Devolx B, Henry JF, Mundler O, Taieb D 2008 Does (18)F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging 35:2018-2025
33. Tenenbaum F, Groussin L, Foehrenbach H, Tissier F, Gouya H, Bertherat J, Dousset B, Legmann P, Richard B, Bertagna X 2004 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients. Eur J Endocrinol 150:789-792
34. Keyes Jr JW 1995 SUV: standard uptake or silly useless value? J Nucl Med 36:1836-1839
35. Huang SC 2000 Anatomy of SUV. Standardized uptake value. Nucl Med Biol 27:643-646
36. Lee JR, Madsen MT, Bushnel D, Menda Y 2000 A threshold method to improve standardized uptake value reproducibility. Nucl Med Commun 21:685-690
37. Ramos CD, Erdi YE, Gonen M, Riedel E, Yeung HW, Macapinlac HA, Chisin R, Larson SM 2001 FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med 28:155-164
38. Paquet N, Albert A, Foidart J, Hustinx R 2004 Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. J Nucl Med 45: 784-788
39. Bagheri B, Maurer AH, Cone L, Doss M, Adler L 2004 Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med 45:1340-1343
40. Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Langsjo J, Salmi J, Valimaki M, Nagren K, Nuutila P 2004 Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med 45:972-979
41. Lin EC, Helgans R 2002 Adrenal hyperplasia in Cushing's syndrome demonstrated by FDG positron emission tomographic imaging. Clin Nucl Med 27: 516-517
42. Rao SK, Caride VJ, Ponn R, Giakovis E, Lee SH 2004 F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma: imaging features and pathologic correlation. Clin Nucl Med 29:300-302
43. Blake MA, Holalkere NS, Boland GW 2008 Imaging techniques for adrenal lesion characterization. Radiol Clin North Am 46:65-78, vi
44. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR 1998 Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201-204
45. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, Raghupathi KI 2002 Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222:629-633
46. Blake MA, Kalra MK, Sweeney AT, Lucey BC, Maher MM, Sahani DV, Halpern EF, Mueller PR, Hahn PF, Boland GW 2006 Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238:578-585
47. Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K 2007 The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14:587-599